PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies has Increased in the Past Four Years In Vitro Diagnostics (IVD), Cardiovascular Devices and Healthcare IT Markets Attracted the Most PE/VC Investments in 2010 A total of 769 private equity (PE) and venture capital (VC) financing deals took place in 2010, compared to 556 in 2009. In 2010, the in vitro diagnostics (IVD), cardiovascular devices and healthcare IT markets attracted the most PE/VC investments, with shares of 20%, 13% and 10% respectively. Within the IVD devices categories, it is the immunochemistry and clinical chemistry categories that are gaining investor attention. In the cardiovascular devices market, it is interventional cardiology that has proved attractive. In interventional cardiology, minimally invasive techniques are being widely chosen by the patient population, thus resulting in the uptake of catheter approaches for congestive heart failure, mitral valve repair and the next generation stents. Large companies are showing an interest and investing in the research and development (R&D) of minimally invasive techniques to treat coronary artery disease and valve repair. For Sample Pages, please click or add the below link to your browser: http://www.gbiresearch.com/RequestSamplePages.aspx?ID=PEVC-Activity-in-Medical-Devices-Numberof-PEVC-Investments-in-Small-Sized-Medical-Devices-Companies-has-Increased-in-the-Past-FourYears&Title=Medical_Devices&ReportType=Industry_Report In 2010, the various stages of medical devices companies in which PE/VC funding was aimed at start-up medical device firms with 53% of the total 769 deals. The second most adopted strategy for investment was in the expansion stage, with 21%, followed by later stage investments, with 16%. PE/VC funding was adopted by investors and medical device companies to give high speed access to new advanced technologies and avoid barriers to entry, expand their portfolio of products and to improve their asset valuations. From 2007–2010, PE/VCs increased their financial investments in the medical device market because of the apparent high potential of the North American and European healthcare sectors. VC firms invest in early-stage companies with high potential for future growth. Similarly, PE firms invest in start-ups, and help them to streamline their operations. Start-up companies in medical devices are started by innovators who have little knowledge or experience of entrepreneurship. PE/VCs help these companies by providing adequate management support. GBI Research’s report, “PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years” provides key data, information and analysis on the global medical devices market. The report provides private equity and venture capital (PE/VC) activity in 18 medical device market categories – In Vitro Diagnostics, Cardiovascular Devices, Orthopedic Devices, Anesthesia and Respiratory Devices, Dental Devices, Diabetes Care devices, Diagnostic Imaging, Drug Delivery Devices, Endoscopy Devices, Ear, Nose and Throat Devices, Healthcare IT, Hospital Supplies, Nephrology and Urology,
Neurology Devices, Ophthalmic Devices, Patient Monitoring, Surgical Equipment and Wound Care Management. The report provides comprehensive information on the factors affecting PE/VC investment in these categories. The report also reviews the detailed analysis of the PE/VC deals worth greater than $100m in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. For further details, please click or add the below link to your browser: http://www.gbiresearch.com/Report.aspx?ID=PEVC-Activity-in-Medical-Devices-Number-of-PEVCInvestments-in-Small-Sized-Medical-Devices-Companies-has-Increased-in-the-Past-FourYears&Title=Medical_Devices&ReportType=Industry_Report Visit our report store: http://www.gbiresearch.com For more details contact: pressreleases@gbiresearch.com North America: Europe: Asia Pacific:
+1 646 395 5477 +44 207 753 4299 +44 1204 543 533 +91 40 6616 6782